Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by InMed Pharmaceuticals Inc. InMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business Update February 17, 2023 From InMed Pharmaceuticals Inc. Via GlobeNewswire Tickers INM InMed Submits Form 12b-25 February 09, 2023 From InMed Pharmaceuticals Inc. Via GlobeNewswire Tickers INM InMed Provides Business Update and Milestones for 2023 January 10, 2023 From InMed Pharmaceuticals Inc. Via GlobeNewswire Tickers INM InMed Announces Results of 2022 Annual General Meeting December 15, 2022 From InMed Pharmaceuticals Inc. Via GlobeNewswire Tickers INM InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor December 12, 2022 From InMed Pharmaceuticals Inc. Via GlobeNewswire Tickers INM InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market November 21, 2022 From InMed Pharmaceuticals Inc. Via GlobeNewswire Tickers INM InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market November 18, 2022 From InMed Pharmaceuticals Inc. Via GlobeNewswire Tickers INM InMed Provides Update on Management Changes November 17, 2022 From InMed Pharmaceuticals Inc. Via GlobeNewswire Tickers INM InMed Pharmaceuticals Advances Neurodegenerative Disease Program with Natural Sciences and Engineering Research Council of Canada ("NSERC") Alliance Grant Funding November 16, 2022 From InMed Pharmaceuticals Inc. Via GlobeNewswire Tickers INM InMed Pharmaceuticals Reports First Quarter Fiscal 2023 Financial Results and Provides Business Update November 11, 2022 From InMed Pharmaceuticals Inc. Via GlobeNewswire Tickers INM Registration Now Open For Tribe Public’s Webinar Event "Exploring the Neuroprotective Qualities of Rare Cannabinoids" Featuring InMed’s Management Team On November 17, 2022 November 10, 2022 From InMed Pharmaceuticals Inc. Via GlobeNewswire Tickers INM InMed Pharmaceuticals Supports Epidermolysis Bullosa Awareness Week October 26, 2022 From InMed Pharmaceuticals Inc. Via GlobeNewswire Tickers INM Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.